Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Height outcome of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency: a meta-analysis.

Massart F, Bizzi M, Baggiani A, Miccoli M.

Pharmacogenomics. 2013 Apr;14(6):607-12. doi: 10.2217/pgs.13.44.

PMID:
23570464
2.

Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.

Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.

Horm Res. 2009;71(3):167-72. doi: 10.1159/000197874. Epub 2009 Feb 3.

PMID:
19188742
3.

Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.

Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA.

J Clin Endocrinol Metab. 2010 Jan;95(1):328-32. doi: 10.1210/jc.2009-1577. Epub 2009 Nov 19.

4.

Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.

Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, Welch K, Bryant J.

Health Technol Assess. 2010 Sep;14(42):1-209, iii-iv. doi: 10.3310/hta14420. Review.

5.

Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.

Iughetti L, Vannelli S, Street ME, Pirazzoli P, Bertelloni S, Radetti G, Capone L, Stasiowska B, Mazzanti L, Gastaldi R, Maggio MC, Predieri B.

Horm Res Paediatr. 2012;78(5-6):279-87. doi: 10.1159/000345354. Epub 2012 Nov 28.

PMID:
23208451
6.

Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.

Binder G, Schwarze CP, Ranke MB.

J Clin Endocrinol Metab. 2000 Jan;85(1):245-9.

PMID:
10634394
7.

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.

Munns CF, Berry M, Vickers D, Rappold GA, Hyland VJ, Glass IA, Batch JA.

J Pediatr Endocrinol Metab. 2003 Sep;16(7):997-1004.

PMID:
14513876
8.

Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.

Iughetti L, Madeo S, Predieri B.

J Endocrinol Invest. 2010 Jun;33(6 Suppl):34-8.

PMID:
21057184
9.

Unique deletion in exon 5 of SHOX gene in a patient with idiopathic short stature.

Shanske AL, Puri M, Marshall B, Saenger P.

Horm Res. 2007;67(2):61-6. Epub 2006 Oct 6.

PMID:
17028440
10.

Effectiveness of rhGH treatment on final height of renal-transplant recipients in childhood.

Gil S, Vaiani E, Guercio G, Ciaccio M, Turconi A, Delgado N, Rivarola MA, Belgorosky A.

Pediatr Nephrol. 2012 Jun;27(6):1005-9. doi: 10.1007/s00467-011-2090-8. Epub 2012 Jan 26.

PMID:
22278170
11.

Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis.

Massart F, Miccoli M, Baggiani A, Bertelloni S.

Pharmacogenomics. 2015 Nov;16(17):1965-73. doi: 10.2217/pgs.15.129. Epub 2015 Nov 10.

PMID:
26555758
12.

The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature.

Wong SC, Hassan K, McGrogan P, Weaver LT, Ahmed SF.

J Pediatr Endocrinol Metab. 2007 Dec;20(12):1315-24.

PMID:
18341091
13.

Short stature caused by isolated SHOX gene haploinsufficiency: update on the diagnosis and treatment.

Jorge AA, Funari MF, Nishi MY, Mendonca BB.

Pediatr Endocrinol Rev. 2010 Dec;8(2):79-85. Review.

PMID:
21150837
14.

The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.

Donze SH, Meijer CR, Kant SG, Zandwijken GR, van der Hout AH, van Spaendonk RM, van den Ouweland AM, Wit JM, Losekoot M, Oostdijk W.

Eur J Endocrinol. 2015 Nov;173(5):611-21. doi: 10.1530/EJE-15-0451. Epub 2015 Aug 11.

15.

The SHOX gene and the short stature. Roundtable on diagnosis and treatment of short stature due to SHOX haploinsufficiency: how genetics, radiology and anthropometry can help the pediatrician in the diagnostic process Padova (April 20th, 2011).

De Sanctis V, Tosetto I, Iughetti L, Antoniazzi F, Clementi M, Toffolutti T, Facchin P, Monti E, Pisanello L, Tonini G, Greggio NA.

Pediatr Endocrinol Rev. 2012 Aug;9(4):727-33.

PMID:
23304810
16.

Use of growth hormone in children.

Hindmarsh PC, Dattani MT.

Nat Clin Pract Endocrinol Metab. 2006 May;2(5):260-8. Review.

PMID:
16932297
17.

Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.

Root AW, Kemp SF, Rundle AC, Dana K, Attie KM.

J Pediatr Endocrinol Metab. 1998;11(3):403-12.

PMID:
11517956
18.

[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].

Jorge AA, Nishi MY, Funari MF, Souza SC, Arnhold IJ, Mendonça BB.

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):765-73. Review. Portuguese.

19.

Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.

Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.

J Pediatr Endocrinol Metab. 1998;11 Suppl 3:845-9.

PMID:
10091155
20.

Supplemental Content

Support Center